Clinical trial Recruiting at 1 site Observational

Identifying genetic causes of growth and puberty disorders

Official title: Identifying New Genetic Causes to the Disorders of Growth, Puberty and Sex Development

Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT03283852 · Data updated 2026-11-12

This study is trying to find new genetic changes that might cause growth and puberty disorders by looking at blood samples from patients with these conditions.

Quick facts

Study typeObservational
SexAll
Enrollment1100 (estimated)
SponsorFondation Ophtalmologique Adolphe de Rothschild
Research network
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 21, 2017
Main results expectedFebruary 21, 2027
Study endsFebruary 21, 2027
Registry record updatedJune 5, 2024
Trial IDNCT03283852 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with congenital growth hormone deficiency, puberty disorders, gonadal dysgenesis, anorchia, primary ovarian failure, or disorders of sex development.

Probably not a fit

Patients with disorders caused by environmental or autoimmune factors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify new genetic mutations associated with disorders of growth, puberty, and sex development through exome analysis. By analyzing blood samples from patients with specific conditions, the study seeks to uncover the frequency of these mutations and their potential links to other malformations. The findings could enhance understanding of the genetic underpinnings of these disorders and inform future treatment strategies.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and management of genetic disorders affecting growth and puberty.

How similar studies have gone: Other studies have successfully identified genetic causes of similar disorders, suggesting a promising approach for this investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* congenital growth hormone deficiency
* puberty disorder
* gonadal dysgenesis or anorchia
* primary ovarian failure
* disorder of sex development
* subjects related to a patient with one of the above criteria

Exclusion Criteria:

* environmental or auto-immune cause

Where it's running

  • Hôpital Fondation A de Rothschild
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Raja Brauner, PU-PH — Hôpital Fondation A. de Rothschild
  • Study coordinator: Amélie YAVCHITZ, MD, PHD
  • Email: ayavchitz@for.paris
  • Phone: 01 48 03 64 54

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.